Guardian Pharmacy Services, Inc. GRDN
49.64 USD -0.20 (-0.41%)
Nov 11, 2026, 9:42 AM EST
49.28 Day range 49.73
26.34 52-week range 50.17
- YTD
- +64.97%
- 1 year
- +58.85%
News
zacks.com NBIX or GRDN: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Drugs sector have probably already heard of Neurocrine Biosciences (NBIX) and Guardian Pharmacy Services (GRDN). But which of these two stocks…
zacks.com NBIX vs. GRDN: Which Stock Is the Better Value Option? Investors looking for stocks in the Medical - Drugs sector might want to consider either Neurocrine Biosciences (NBIX) or Guardian Pharmacy Services (GRDN). But which of these two companies is the…
marketbeat.com What Guardian Pharmacy Services (GRDN) Said on Its Q3 Earnings Call Guardian Pharmacy Services NYSE: GRDN raised its full-year revenue and adjusted EBITDA guidance after third-quarter profit rose on higher prescription volumes, improved reimbursement and purchasing…
seekingalpha.com Guardian Pharmacy Services, Inc. (GRDN) Q3 2026 Earnings Call Transcript Guardian Pharmacy Services, Inc. ( GRDN ) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST Company Participants Ashley Stockton - Head of Investor Relations & Senior Director Fred Burke - CEO,…
zacks.com Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.25 per share a year ago.
benzinga.com Guardian Pharmacy Service Q3 2026 Earnings Call Transcript Guardian Pharmacy Service (NYSE:GRDN) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
benzinga.com Guardian Pharmacy Service Raises FY2026 Sales Guidance from $1.430B-$1.450B to $1.440B-$1.460B vs $1.442B Est Guardian Pharmacy Service (NYSE:GRDN) raises FY2026 sales outlook from $1.430 billion-$1.450 billion to $1.440 billion-$1.460 billion vs $1.442 billion estimate.
businesswire.com Guardian Pharmacy Services Reports Third Quarter 2026 Financial Results; Raises Full-Year Guidance ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the…
benzinga.com Transcript: Guardian Pharmacy Service Q2 2026 Earnings Conference Call Guardian Pharmacy Service (NYSE:GRDN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs.…
benzinga.com This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.
benzinga.com Keybanc Initiates Coverage On Guardian Pharmacy Service with Overweight Rating, Announces Price Target of $52 Keybanc analyst Zach Haggerty initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Overweight rating and announces Price Target of $52.
benzinga.com Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $51 Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $47 to $51.
benzinga.com Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49 Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $43 to $49.
benzinga.com Guardian Pharmacy Service Q2 Adj. EPS $0.29 Beats $0.27 Estimate, Sales $351.768M Beat $340.045M Estimate Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.27 by 7.41 percent. This is a 26.09 percent increase over earnings…- benzinga.com Guardian Pharmacy Service Raises FY2026 Sales Guidance from $1.400B-$1.420B to $1.430B-$1.450B vs $1.415B Est Guardian Pharmacy Service (NYSE:GRDN) raises FY2026 sales outlook from $1.400 billion-$1.420 billion to $1.430 billion-$1.450 billion vs $1.415 billion estimate.
- benzinga.com Guardian Pharmacy Services Acquires Wellness Concepts; Terms Not Disclosed Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation’s largest and most innovative long-term care (LTC) pharmacy services companies, today announced the acquisition of Wellness Concepts,…
- benzinga.com Guardian Pharmacy Services Appoints CFO David Morris As COO, Effective July 1 Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since 2004, has decided to retire, effective as of…
- benzinga.com Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47 Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $43 to $47.
- benzinga.com B of A Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47 B of A Securities analyst Allen Lutz maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $42 to $47.
benzinga.com Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $43 Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $38 to $43.
benzinga.com Earnings Scheduled For May 6, 2026 - benzinga.com Guardian Pharmacy Service Affirms FY2026 Sales Guidance of $1.400B-$1.420B vs $1.413B Est Guardian Pharmacy Service (NYSE:GRDN) affirms FY2026 sales outlook from $1.400 billion-$1.420 billion to $1.400 billion-$1.420 billion vs $1.413 billion estimate.
- benzinga.com Guardian Pharmacy Service Q1 Adj. EPS $0.29 Beats $0.23 Estimate, Sales $336.595M Beat $329.485M Estimate Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.23 by 26.09 percent. This is a 93.33 percent increase over…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session 
benzinga.com This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Top Wall Street analysts changed outlook on top names. See analyst rating changes, including upgrades/downgrades/initiations, on Benzinga.- benzinga.com B of A Securities Initiates Coverage On Guardian Pharmacy Service with Buy Rating, Announces Price Target of $42 B of A Securities analyst Allen Lutz initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Buy rating and announces Price Target of $42.
- benzinga.com Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $43 Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $38 to $43.
- benzinga.com Jefferies Initiates Coverage On Guardian Pharmacy Service with Buy Rating, Announces Price Target of $44 Jefferies analyst Brian Tanquilut initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Buy rating and announces Price Target of $44.
benzinga.com Stock Market Today: S&P 500, Dow Jones Futures Slip As Jobless Claims Fall To 205,000— Micron, FedEx, Constellation Energy In Focus (UPDATED) (Editor’s note: The future prices of benchmark tracking ETFs, the lede, and the headline were updated in the story.) U.S. stock futures fell on Thursday following Wednesday’s declines. Futures of the…
benzinga.com Alibaba Posts Downbeat Earnings, Joins Guardian Pharmacy, Micron And Other Big Stocks Moving Lower In Thursday's Pre-Market Session Stock futures slightly lower, Alibaba falls after downbeat earnings, other stocks decline in pre-market trading.- benzinga.com Guardian Pharmacy Services Prices Its Upsized Public Offering Of 6M Shares At $31/Share Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the pricing of its upsized underwritten public offering (the "Offering") of 6,000,000 shares of its Class A common stock at a…
benzinga.com Why Five Below Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket Five Below Inc (FIVE) shares rose 7.2% in pre-market trading after reporting better-than-expected Q4 results and issuing strong FY26 EPS guidance. Other gainers include LBGJ, ASNS, SVRN, SUNE, MDAI,…
benzinga.com Micron, Accenture And 3 Stocks To Watch Heading Into Thursday US stock futures mixed on Thursday, with focus on Accenture, Micron, Alibaba's earnings. Guardian Pharmacy announces public offering.- benzinga.com Guardian Pharmacy Announces Launch Of Proposed Public Offering Of 5M Shares The Offering for GRDN's Class A common stock, consisting of 3,980,000 shares being offered by certain selling stockholders and 1,020,000 newly issued shares being offered by Guardian as part of a…
- benzinga.com Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $38 Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $35 to $38.
benzinga.com Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $38 Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $34 to $38.
benzinga.com Guardian Pharmacy Service Affirms FY2026 Sales Guidance of $1.400B-$1.420B Guardian Pharmacy Service (NYSE:GRDN) affirms FY2026 sales outlook from $1.400 billion-$1.420 billion to $1.400 billion-$1.420 billion.- benzinga.com Guardian Pharmacy Service Q4 EPS $0.33 Beats $0.21 Estimate, Sales $397.616M Beat $389.147M Estimate Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.21 by 53.49 percent. This is a 73.68 percent increase over…
- benzinga.com Earnings Scheduled For March 11, 2026
benzinga.com What to Expect from Guardian Pharmacy Service's Earnings - benzinga.com Stephens & Co. Maintains Overweight on Guardian Pharmacy Service, Raises Price Target to $36 Stephens & Co. analyst Scott Fidel maintains Guardian Pharmacy Service (NYSE:GRDN) with a Overweight and raises the price target from $35 to $36.
- benzinga.com Guardian Pharmacy Services Reiterates Its Previously Announced 2025 Revenue Guidance Of $1.43B To $1.45B; For 2026, Co. Expects Revenue In The Range Of $1.40B To $1.42B Guardian Pharmacy Services (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, is reiterating its previously announced 2025 guidance and providing its…
- benzinga.com Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $34 Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $30 to $34.
- benzinga.com Guardian Pharmacy Service Raises FY2025 Sales Guidance from $1.390B-$1.410B to $1.430B-$1.450B vs $1.401B Est FY 2025 Outlook – Raising GuidanceThe updated guidance below excludes future acquisitions. Updated GuidancePrevious GuidanceRevenue$1.43 billion - $1.45 billion$1.39 billion - $1.41 billionAdjusted…
benzinga.com Earnings Scheduled For November 10, 2025 - benzinga.com Oppenheimer Initiates Coverage On Guardian Pharmacy Service with Outperform Rating, Announces Price Target of $30 Oppenheimer analyst Michael Wiederhorn initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Outperform rating and announces Price Target of $30.
- benzinga.com Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $30 Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE: GRDN) with a Buy and raises the price target from $28 to $30.
- benzinga.com Guardian Pharmacy Service Raises FY2025 Sales Guidance from $1.330B-$1.350B to $1.390B-$1.410B vs $1.349B Est Guardian Pharmacy Service (NYSE:GRDN) raises FY2025 sales outlook from $1.330 billion-$1.350 billion to $1.390 billion-$1.410 billion vs $1.349 billion estimate.
- benzinga.com Guardian Pharmacy Service Q2 Adj. EPS $0.23 Beats $0.15 Estimate, Sales $344.334M Beat $329.816M Estimate Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.15 by 48.39 percent. The company reported quarterly sales of…
- benzinga.com Earnings Scheduled For August 11, 2025